Philips North America vs Roche Diabetes Care, Inc.: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Roche Diabetes Care, Inc..

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Roche Diabetes Care, Inc.: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Side by side

Philips North America — Warning letters0

Roche Diabetes Care, Inc. — Warning letters0

Philips North America — Recalls355

Roche Diabetes Care, Inc. — Recalls1

Philips North America — Approval records0

Roche Diabetes Care, Inc. — Approval records0

Philips North America — Form 483s0

Roche Diabetes Care, Inc. — Form 483s0

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Roche Diabetes Care, Inc.

Most recent FDA action: July 3, 2024

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs Roche Diabetes Care, Inc.: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/philips-north-america-vs-roche-diabetes-care-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗